Elevated levels of acute-phase proteins (e.g. CRP) as well as several cytokines (e.g. IL-1β, IL-6) are present in T2D patients and are shown to be modulated during disease progression [15]. The gene discussed is CRP; the disease is type 2 diabetes mellitus.